Youngs Advisory Group, Inc. Astrazeneca PLC Transaction History
Youngs Advisory Group, Inc.
- $240 Million
- Q1 2025
A detailed history of Youngs Advisory Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Youngs Advisory Group, Inc. holds 3,820 shares of AZN stock, worth $266,941. This represents 0.12% of its overall portfolio holdings.
Number of Shares
3,820
Previous 3,350
14.03%
Holding current value
$266,941
Previous $219,000
27.85%
% of portfolio
0.12%
Previous 0.09%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.99 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.84 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.49 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.22 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.19 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $217B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...